Bridgewater Associates, LP
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1350694
Westport, CT
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,557,471
-$38,592,212 QoQ
Shares Held
22,724
-68.8% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bridgewater Associates, LP holds $275,081,004 across 28 Biotechnology names. REGN ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
295,579 | $48,333,078 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
106,592 | $35,268,095 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
511,429 | $33,053,656 | |
| 4 | EXEL |
Exelixis, Inc.
|
480,996 | $20,629,918 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
259,459 | $19,267,425 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
22,724 | $17,557,471 | |
| 7 | INCY |
Incyte Corp
|
130,296 | $12,263,459 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
46,367 | $11,977,523 |
All Filings in REGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,557,471 | 22,724 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $56,149,683 | 72,745 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $132,347,674 | 235,381 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $46,749,675 | 89,047 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $13,313,121 | 20,991 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $205,863 | 289 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $585,540 | 557 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,627,214 | 5,354 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $58,852,413 | 61,146 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $96,727,834 | 110,132 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $49,993,997 | 60,749 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $72,524,397 | 100,933 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $53,324,739 | 64,898 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $28,052,252 | 38,881 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $39,594,180 | 57,477 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $43,684,507 | 73,900 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,807,785 | 5,452 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,758,503 | 7,535 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,491,645 | 7,422 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,085,079 | 12,685 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||